The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 08, 2024

Filed:

Aug. 05, 2022
Applicant:

Nxstage Medical, Inc., Lawrence, MA (US);

Inventors:

Jeffrey H. Burbank, Manchester, MA (US);

Dennis M. Treu, Castle Rock, CO (US);

James M. Brugger, Newburyport, MA (US);

Assignee:

NxStage Medical, Inc., Lawrence, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G08B 19/00 (2006.01); A61B 5/00 (2006.01); A61B 5/01 (2006.01); A61B 5/08 (2006.01); A61B 5/117 (2016.01); A61M 1/14 (2006.01); A61M 1/36 (2006.01); G05B 1/01 (2006.01); G05B 9/02 (2006.01); G08B 21/18 (2006.01); G08B 21/22 (2006.01); G08B 23/00 (2006.01); G16H 30/40 (2018.01); G16H 40/63 (2018.01); G16H 40/67 (2018.01); G16Z 99/00 (2019.01); G16H 20/00 (2018.01);
U.S. Cl.
CPC ...
G16H 40/63 (2018.01); A61B 5/0077 (2013.01); A61B 5/015 (2013.01); A61B 5/0816 (2013.01); A61B 5/117 (2013.01); A61B 5/746 (2013.01); A61B 5/7475 (2013.01); A61M 1/14 (2013.01); A61M 1/36 (2013.01); A61M 1/367 (2013.01); G05B 1/01 (2013.01); G05B 9/02 (2013.01); G08B 21/182 (2013.01); G08B 21/22 (2013.01); G16H 30/40 (2018.01); G16H 40/67 (2018.01); G16Z 99/00 (2019.02); A61M 2205/18 (2013.01); A61M 2205/3553 (2013.01); A61M 2205/6009 (2013.01); G16H 20/00 (2018.01);
Abstract

A medical treatment device is configured to be used during a treatment session at a first location and includes a medical treatment component configured to perform at least one of hemodialysis, hemofiltration, and peritoneal dialysis on a patient during the treatment session at the first location. The device also includes a monitoring system configured to receive data from one or more sensors connected to the monitoring system, and to confirm a presence of an authorized helper at the first location. A user interface permits an operator to control functions of the medical treatment component and the monitoring system is configured to perform the presence confirmation automatically and at the predefined time intervals during the treatment session. The monitoring system is also configured to generate an alarm and to cause the medical treatment component to go into a failsafe operational mode.


Find Patent Forward Citations

Loading…